Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesMachine, Furnitures, Fixtures & OtherNon-Current ReceivablesOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetReceivables RefundsShort-Term Debt repayments
Ratios

Cue Biopharma (CUE) Shares Repurchased (2020 - 2022)

Cue Biopharma's Shares Repurchased history spans 3 years, with the latest figure at $9000.0 for Q3 2022.

  • For Q3 2022, Shares Repurchased fell 98.13% year-over-year to $9000.0; the TTM value through Jun 2023 reached $9000.0, down 98.95%, while the annual FY2022 figure was $200000.0, 73.34% down from the prior year.
  • Shares Repurchased for Q3 2022 was $9000.0 at Cue Biopharma, down from $191000.0 in the prior quarter.
  • Across five years, Shares Repurchased topped out at $482000.0 in Q3 2021 and bottomed at $9000.0 in Q3 2022.
  • The 3-year median for Shares Repurchased is $160051.0 (2020), against an average of $163597.0.
  • The largest annual shift saw Shares Repurchased skyrocketed 1277.14% in 2021 before it crashed 98.13% in 2022.
  • A 3-year view of Shares Repurchased shows it stood at $160051.0 in 2020, then rose by 14.42% to $183128.0 in 2021, then tumbled by 95.09% to $9000.0 in 2022.
  • Per Business Quant, the three most recent readings for CUE's Shares Repurchased are $9000.0 (Q3 2022), $191000.0 (Q1 2022), and $183128.0 (Q4 2021).